At the risk of sounding self-congratulatory, rewinding to our last update of 3rd November, the closing statement was to buy stocks whilst prices were, in our opinion, artificially low. The tenor of our last publication was that when the news is generally bad, stocks are...
Within our regular fortnightly communication last week, we did say we would write more fully once we had properly considered the setback to world stock markets which occurred last Wednesday, the day before we went to press. There is a saying in markets, one of many...
Stop-press The article below was written on 27th October and prepared for issue the day after, on the very day US markets went into tailspin. The S&P500 fell 3.5% yesterday on election uncertainty and the continuing battle with containing COVID, alongside the potential for further economic...
After a brief excursion into US politics in the last bulletin, this edition sees a return to the issue perhaps uppermost in investors’ minds, and that is the prognosis for financial markets. But before we get to that, it is worth a reminder of what...
Since the start of the COVID crisis, our aim has been to communicate our view on financial markets weekly before reverting to fortnightly in April but this latest edition, for a number of reasons, is a week late. We apologise for this, but will ensure...
As we edge towards September and the Coronavirus crisis enters its ninth month, the titles of the fortnightly CDC update appear, at first glance, to get more outlandish. This is not the result of cabin fever on my part, but in the case of this...
It will not have escaped the attention of many who read the financial press that the star asset performance this year, apart from Tesla shares, has come from gold. We will leave Tesla for another briefing but the precious metal is up by a whopping...
Some time ago I wrote a piece about the problems of benchmarks in the financial world. Having just issued the half yearly profile reports, where we talk about CDC performance against a benchmark, it seems an appropriate time to revisit the issue. The Financial Conduct Authority...
Many of you will have spoken to or even met, Alex Smith who has been supporting Phil Cain admirably since he joined CDC. Alex has progressed with his professional exams with such alacrity that he should soon be ready to move into an adviser role...
Following our ‘bumper edition’ a fortnight ago, this latest bulletin has a more slim-line feel about it. That there is nothing much to write about could not be further from the truth. We are currently working on the half-yearly Profile Reports which will provide a...